EU Lists Spinal Cord Inflammation Probable Side Effect Of JNJ's COVID-19 Shot: Reuters

European Medicines Agency (EMA) recommended adding transverse myelitis, a rare type of spinal inflammation, as a side-effect of the Johnson & Johnson's JNJ COVID-19 vaccine.
Giving updates on the safety of all coronavirus shots, the EMA said it was assessing reports of capillary leak syndrome, a rare blood condition after Moderna Inc's MRNA vaccine.
The EMA said it had recorded six cases of capillary leak syndrome and was assessing all data, but it was not yet clear if there was a causal association between the reports and the vaccine.
The EMA said there was insufficient evidence of a possible link between rare cases of the multisystem inflammatory syndrome and mRNA-based vaccines from Moderna and Pfizer Inc PFE - BioNTech SE BNTX vaccine.
Price Action: JNJ shares traded lower by 0.83 at $162.90 on the last check Thursday.